Discussion: The process of explaining experimental drugs to life-threatening patients must consider that they cling to every glimmer of hope, sometimes without fully knowing or understanding the alternatives and consequences.

The Helsinki Committee must approve the use of experimental drugs, but the patient information process is immense. The explanations for the nature of the treatment, the chances of recovery, and the risks and side effects must be apparent. The patient's written consent is insufficient; They are sometimes willing to try anything. When the patient lacks primary education, there is a double meaning to a plausible explanation if the medical institution is directly or indirectly interested in promoting the relevant research! The subject must be expressed appropriately orally and in writing explicitly.